Aug 26, 2026 04:08PM
Aug 26, 2026 04:07PM
Aug 6, 2026 04:05PM
Jul 17, 2026 04:05PM
Jul 6, 2026 04:01PM
Jul 6, 2026 04:01PM
Jun 26, 2026 08:01AM Vaxart urges shareholder vote ahead of July proxy contest
Jun 26, 2026 08:00AM
Jun 25, 2026 08:03AM
Jun 25, 2026 08:00AM
Jun 16, 2026 08:00AM
Jun 8, 2026 08:00AM
Jun 1, 2026 08:18AM
May 19, 2026 04:01PM Vaxart files proxy materials, faces shareholder challenge at annual meeting
May 19, 2026 04:01PM
May 7, 2026 04:05PM
Apr 23, 2026 04:30PM
Apr 23, 2026 04:30PM
Apr 17, 2026 08:31AM
Apr 17, 2026 08:30AM
Mar 12, 2026 04:05PM Vaxart Provides Business Update and Reports Full Year 2025 Financial Results
Jan 15, 2026 08:00AM
Nov 13, 2025 04:05PM
Nov 5, 2025 04:00PM
Nov 5, 2025 04:00PM
Sep 10, 2025 04:55PM
Sep 10, 2025 04:54PM
Aug 13, 2025 04:05PM Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
Jun 11, 2025 07:30AM
Jun 11, 2025 07:30AM
May 27, 2025 08:00AM
May 15, 2025 08:01AM
May 15, 2025 08:00AM
May 14, 2025 04:05PM
May 13, 2025 04:05PM Vaxart Provides Business Update and Reports First Quarter 2025 Financial Results
May 13, 2025 04:02PM
May 13, 2025 04:01PM
Apr 30, 2025 08:01AM
Apr 30, 2025 08:00AM
Mar 20, 2025 04:01PM
Mar 11, 2025 08:00AM
Mar 5, 2025 04:06PM Vaxart (VXRT) Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
Mar 5, 2025 04:05PM
Jan 28, 2025 08:02AM
Jan 28, 2025 08:00AM
Jan 14, 2025 08:07AM
Jan 14, 2025 08:00AM
Jan 13, 2025 07:55PM
Dec 2, 2024 04:01PM Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
Nov 13, 2024 04:01PM

329,975 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All